MovDisordV3, Main, Exploration, bibRecord, 002575

The relationship between CAG repeat length and clinical progression in Huntington's disease

Identifieur interne : 002575 ( Main/Exploration ); précédent : 002574; suivant : 002576

The relationship between CAG repeat length and clinical progression in Huntington's disease

Auteurs : Bernard Ravina [États-Unis] ; Megan Romer [États-Unis] ; Radu Constantinescu [Suède] ; Kevin Biglan [États-Unis] ; Alicia Brocht [États-Unis] ; Karl Kieburtz [États-Unis] ; Ira Shoulson [États-Unis] ; Michael P. Mcdermott [États-Unis]

Source :

Movement Disorders [ 0885-3185 ] ; 2008-07-15.

RBID : ISTEX:A1AA67C89660DD2558633FA4C8C6482BC5025296

Descripteurs français

Pascal (Inist)
- Chorée de Huntington, Pathologie du système nerveux.

English descriptors

KwdEn :
- Adult, Aged, Disease Progression, Female, Humans, Huntington Disease (genetics), Huntington Disease (physiopathology), Huntington disease, Huntington's disease, Male, Middle Aged, Nervous system diseases, Neuropsychological Tests, Regression Analysis, Retrospective Studies, Trinucleotide Repeat Expansion, progression, repeat length.
MESH :
- genetics : Huntington Disease.
- physiopathology : Huntington Disease.
- Adult, Aged, Disease Progression, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Regression Analysis, Retrospective Studies, Trinucleotide Repeat Expansion.

Abstract

The objective of this study was to examine the relationship between CAG repeat length (CAGn) and clinical progression in patients with Huntington's disease (HD). There are conflicting reports about the relationship between CAGn and clinical progression of HD. We conducted an analysis of data from the Coenzyme Q10 and Remacemide Evaluation in Huntington's Disease (CARE‐HD) clinical trial. We modeled progression over 30 months on the Unified Huntington's Disease Rating Scale (UHDRS) and supplemental neuropsychological and behavioral tests using multiple linear regression. Mean subject age was 47.9 ± 10.5 years and mean CAGn was 45.0 ± 4.1. Multiple linear regression revealed statistically significant associations between CAGn and worsening on several motor, cognitive, and functional outcomes, but not behavioral outcomes. Many effects were clinically important; 10 additional CAG repeats were associated with an 81% increase in progression on the Independence Scale. These associations were not observed in the absence of age adjustment. Age at the time of assessment confounds the association between CAGn and progression. Adjusting for age shows that longer CAGn is associated with greater clinical progression of HD. This finding may account for the variable results from previous studies examining CAGn and progression. Adjusting for CAGn may be important for clinical trials. © 2008 Movement Disorder Society

Url:

https://api.istex.fr/document/A1AA67C89660DD2558633FA4C8C6482BC5025296/fulltext/pdf

DOI: 10.1002/mds.21988

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The relationship between CAG repeat length and clinical progression in Huntington's disease</title>
<author><name sortKey="Ravina, Bernard" sort="Ravina, Bernard" uniqKey="Ravina B" first="Bernard" last="Ravina">Bernard Ravina</name>
</author>
<author><name sortKey="Romer, Megan" sort="Romer, Megan" uniqKey="Romer M" first="Megan" last="Romer">Megan Romer</name>
</author>
<author><name sortKey="Constantinescu, Radu" sort="Constantinescu, Radu" uniqKey="Constantinescu R" first="Radu" last="Constantinescu">Radu Constantinescu</name>
</author>
<author><name sortKey="Biglan, Kevin" sort="Biglan, Kevin" uniqKey="Biglan K" first="Kevin" last="Biglan">Kevin Biglan</name>
</author>
<author><name sortKey="Brocht, Alicia" sort="Brocht, Alicia" uniqKey="Brocht A" first="Alicia" last="Brocht">Alicia Brocht</name>
</author>
<author><name sortKey="Kieburtz, Karl" sort="Kieburtz, Karl" uniqKey="Kieburtz K" first="Karl" last="Kieburtz">Karl Kieburtz</name>
</author>
<author><name sortKey="Shoulson, Ira" sort="Shoulson, Ira" uniqKey="Shoulson I" first="Ira" last="Shoulson">Ira Shoulson</name>
</author>
<author><name sortKey="Mcdermott, Michael P" sort="Mcdermott, Michael P" uniqKey="Mcdermott M" first="Michael P." last="Mcdermott">Michael P. Mcdermott</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A1AA67C89660DD2558633FA4C8C6482BC5025296</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21988</idno>
<idno type="url">https://api.istex.fr/document/A1AA67C89660DD2558633FA4C8C6482BC5025296/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001F08</idno>
<idno type="wicri:Area/Istex/Curation">001F08</idno>
<idno type="wicri:Area/Istex/Checkpoint">001131</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Ravina B:the:relationship:between</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18512767</idno>
<idno type="wicri:Area/PubMed/Corpus">002208</idno>
<idno type="wicri:Area/PubMed/Curation">002208</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002031</idno>
<idno type="wicri:Area/Ncbi/Merge">002155</idno>
<idno type="wicri:Area/Ncbi/Curation">002155</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002155</idno>
<idno type="wicri:Area/Main/Merge">003153</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:08-0396181</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001202</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001B17</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001049</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Ravina B:the:relationship:between</idno>
<idno type="wicri:Area/Main/Merge">003657</idno>
<idno type="wicri:Area/Main/Curation">002575</idno>
<idno type="wicri:Area/Main/Exploration">002575</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The relationship between CAG repeat length and clinical progression in Huntington's disease</title>
<author><name sortKey="Ravina, Bernard" sort="Ravina, Bernard" uniqKey="Ravina B" first="Bernard" last="Ravina">Bernard Ravina</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Romer, Megan" sort="Romer, Megan" uniqKey="Romer M" first="Megan" last="Romer">Megan Romer</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Department of Statistics, Pennsylvania State University, State College</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Constantinescu, Radu" sort="Constantinescu, Radu" uniqKey="Constantinescu R" first="Radu" last="Constantinescu">Radu Constantinescu</name>
<affiliation wicri:level="1"><country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Neurology, University of Göteborg, Göteborg</wicri:regionArea>
<wicri:noRegion>Göteborg</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Biglan, Kevin" sort="Biglan, Kevin" uniqKey="Biglan K" first="Kevin" last="Biglan">Kevin Biglan</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Brocht, Alicia" sort="Brocht, Alicia" uniqKey="Brocht A" first="Alicia" last="Brocht">Alicia Brocht</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kieburtz, Karl" sort="Kieburtz, Karl" uniqKey="Kieburtz K" first="Karl" last="Kieburtz">Karl Kieburtz</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Shoulson, Ira" sort="Shoulson, Ira" uniqKey="Shoulson I" first="Ira" last="Shoulson">Ira Shoulson</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Mcdermott, Michael P" sort="Mcdermott, Michael P" uniqKey="Mcdermott M" first="Michael P." last="Mcdermott">Michael P. Mcdermott</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<placeName><region type="state">État de New York</region>
</placeName>
<wicri:cityArea>Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-07-15">2008-07-15</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1223">1223</biblScope>
<biblScope unit="page" to="1227">1227</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A1AA67C89660DD2558633FA4C8C6482BC5025296</idno>
<idno type="DOI">10.1002/mds.21988</idno>
<idno type="ArticleID">MDS21988</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Huntington Disease (genetics)</term>
<term>Huntington Disease (physiopathology)</term>
<term>Huntington disease</term>
<term>Huntington's disease</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Neuropsychological Tests</term>
<term>Regression Analysis</term>
<term>Retrospective Studies</term>
<term>Trinucleotide Repeat Expansion</term>
<term>progression</term>
<term>repeat length</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Huntington Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Huntington Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Disease Progression</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neuropsychological Tests</term>
<term>Regression Analysis</term>
<term>Retrospective Studies</term>
<term>Trinucleotide Repeat Expansion</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Chorée de Huntington</term>
<term>Pathologie du   système nerveux</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The objective of this study was to examine the relationship between CAG repeat length (CAGn) and clinical progression in patients with Huntington's disease (HD). There are conflicting reports about the relationship between CAGn and clinical progression of HD. We conducted an analysis of data from the Coenzyme Q10 and Remacemide Evaluation in Huntington's Disease (CARE‐HD) clinical trial. We modeled progression over 30 months on the Unified Huntington's Disease Rating Scale (UHDRS) and supplemental neuropsychological and behavioral tests using multiple linear regression. Mean subject age was 47.9 ± 10.5 years and mean CAGn was 45.0 ± 4.1. Multiple linear regression revealed statistically significant associations between CAGn and worsening on several motor, cognitive, and functional outcomes, but not behavioral outcomes. Many effects were clinically important; 10 additional CAG repeats were associated with an 81% increase in progression on the Independence Scale. These associations were not observed in the absence of age adjustment. Age at the time of assessment confounds the association between CAGn and progression. Adjusting for age shows that longer CAGn is associated with greater clinical progression of HD. This finding may account for the variable results from previous studies examining CAGn and progression. Adjusting for CAGn may be important for clinical trials. © 2008 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Suède</li>
<li>États-Unis</li>
</country>
<region><li>Pennsylvanie</li>
<li>État de New York</li>
</region>
</list>
<tree><country name="États-Unis"><region name="État de New York"><name sortKey="Ravina, Bernard" sort="Ravina, Bernard" uniqKey="Ravina B" first="Bernard" last="Ravina">Bernard Ravina</name>
</region>
<name sortKey="Biglan, Kevin" sort="Biglan, Kevin" uniqKey="Biglan K" first="Kevin" last="Biglan">Kevin Biglan</name>
<name sortKey="Brocht, Alicia" sort="Brocht, Alicia" uniqKey="Brocht A" first="Alicia" last="Brocht">Alicia Brocht</name>
<name sortKey="Kieburtz, Karl" sort="Kieburtz, Karl" uniqKey="Kieburtz K" first="Karl" last="Kieburtz">Karl Kieburtz</name>
<name sortKey="Mcdermott, Michael P" sort="Mcdermott, Michael P" uniqKey="Mcdermott M" first="Michael P." last="Mcdermott">Michael P. Mcdermott</name>
<name sortKey="Romer, Megan" sort="Romer, Megan" uniqKey="Romer M" first="Megan" last="Romer">Megan Romer</name>
<name sortKey="Shoulson, Ira" sort="Shoulson, Ira" uniqKey="Shoulson I" first="Ira" last="Shoulson">Ira Shoulson</name>
</country>
<country name="Suède"><noRegion><name sortKey="Constantinescu, Radu" sort="Constantinescu, Radu" uniqKey="Constantinescu R" first="Radu" last="Constantinescu">Radu Constantinescu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002575 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002575 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A1AA67C89660DD2558633FA4C8C6482BC5025296
   |texte=   The relationship between CAG repeat length and clinical progression in Huntington's disease
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

The relationship between CAG repeat length and clinical progression in Huntington's disease

The relationship between CAG repeat length and clinical progression in Huntington's disease

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.